Results 181 to 190 of about 240,120 (301)

The siderophore transporter Sit1 is involved in the uptake of caspofungin by <i>Candida albicans</i>. [PDF]

Antimicrob Agents Chemother
Pedras A, Amaral C, Conceição C, Malta-Luís C, Pissarro T, V Mariano C, A Lenis-Rojas O, Ventura MR, Pimentel C.   +8 more
europepmc   +1 more source

Candida albicans

, 2003
openaire   +2 more sources

Diagnostic Potential of a Recombinant Candida albicans Hyr1 Protein. [PDF]

Mycopathologia
Bregón-Villahoz M, Díez A, Galech J, Cuétara MS, Carrano G, Moragues MD, Fernandez-de-Larrinoa I, Arrieta-Aguirre I.   +7 more
europepmc   +1 more source

The oral microbiota and periodontal health in orthodontic patients

Periodontology 2000, EarlyView.
Abstract The oral microbiota develops within the first 2 years of childhood and becomes distinct from the parents by 4 years‐of‐age. The oral microbiota plays an important role in the overall health/symbiosis of the individual. Deviations from the state of symbiosis leads to dysbiosis and an increased risk of pathogenicity.
Brandon W. Peterson, Geerten‐Has Tjakkes, Anne‐Marie Renkema, David J. Manton, Yijin Ren   +4 more
wiley   +1 more source

Hgt17-Adr1 Relationship in <i>Candida albicans</i> Citrate Utilization. [PDF]

J Fungi (Basel)
White AM, Mitchell AP.
europepmc   +1 more source

Engineered surface strategies to manage dental implant‐related infections

Periodontology 2000, EarlyView.
Abstract When exposed to the oral environment, dental implants, like natural surfaces, become substrates for microbial adhesion and accumulation, often leading to implant‐related infections—one of the main causes of implant failure. These failures impose significant costs on patients, clinicians, and healthcare systems.
João Gabriel S. Souza, Bruna E. Nagay, Rodrigo Martins, Martinna Bertolini, Jamil A. Shibli, Conrado Aparicio, Magda Feres, Valentim A. R. Barão   +7 more
wiley   +1 more source

Evaluation of Antimicrobials Incorporated into Artificial Saliva: Analysis Against <i>Candida albicans</i>. [PDF]

J Funct Biomater
Carneiro CA, Pontes FML, Neppelenbroek KH, França R, Porto VC.   +4 more
europepmc   +1 more source

Emerging locally delivered antimicrobial and immunomodulatory approaches for the prevention/treatment of peri‐implant diseases

Periodontology 2000, EarlyView.
Abstract Peri‐implant diseases are dysbiosis‐mediated inflammatory disorders that occur in susceptible hosts. Antimicrobials and immunomodulatory agents therefore might be pertinent as adjunctive measures in the treatment of such disorders. The aim of this narrative review was to examine the existing evidence and assess the effectiveness of emerging ...
Alberto Monje, Ettore Amerio, Irene Mallor, Conrado Aparicio   +3 more
wiley   +1 more source

Overcoming Candida albicans biofilm drug resistance via azole-sophorolipid synergy. [PDF]

Sci Rep
Jayasekara LACB, Watchaputi K, Butkinaree C, Soontorngun N.   +3 more
europepmc   +1 more source

Cryptogenic Candida albicans cholecystitis

Journal of British Surgery, 1987
J, Schneiderman, A, Bass, B, Morag
openaire   +2 more sources